オンコリスバイオファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/06/07 | 1,383 | 1,394 | 1,345 | 1,387 | +17 | +1.2% | 215,500 |
| 2021/06/04 | 1,415 | 1,422 | 1,359 | 1,370 | -57 | -4% | 445,400 |
| 2021/06/03 | 1,424 | 1,448 | 1,407 | 1,427 | -6 | -0.4% | 290,100 |
| 2021/06/02 | 1,440 | 1,475 | 1,431 | 1,433 | +4 | +0.3% | 441,000 |
| 2021/06/01 | 1,434 | 1,441 | 1,403 | 1,429 | ±0 | ±0% | 246,100 |
| 2021/05/31 | 1,391 | 1,456 | 1,390 | 1,429 | +51 | +3.7% | 607,700 |
| 2021/05/28 | 1,370 | 1,388 | 1,347 | 1,378 | +20 | +1.5% | 237,400 |
| 2021/05/27 | 1,360 | 1,371 | 1,316 | 1,358 | -2 | -0.1% | 273,700 |
| 2021/05/26 | 1,352 | 1,374 | 1,342 | 1,360 | +8 | +0.6% | 200,600 |
| 2021/05/25 | 1,339 | 1,375 | 1,327 | 1,352 | +42 | +3.2% | 301,900 |
| 2021/05/24 | 1,384 | 1,384 | 1,304 | 1,310 | -58 | -4.2% | 437,700 |
| 2021/05/21 | 1,356 | 1,390 | 1,347 | 1,368 | +33 | +2.5% | 358,800 |
| 2021/05/20 | 1,325 | 1,360 | 1,293 | 1,335 | +3 | +0.2% | 396,800 |
| 2021/05/19 | 1,310 | 1,386 | 1,306 | 1,332 | +12 | +0.9% | 681,900 |
| 2021/05/18 | 1,279 | 1,326 | 1,260 | 1,320 | +44 | +3.4% | 502,600 |
| 2021/05/17 | 1,295 | 1,316 | 1,232 | 1,276 | -2 | -0.2% | 511,400 |
| 2021/05/14 | 1,228 | 1,285 | 1,211 | 1,278 | +38 | +3.1% | 450,300 |
| 2021/05/13 | 1,220 | 1,274 | 1,175 | 1,240 | +39 | +3.2% | 668,900 |
| 2021/05/12 | 1,243 | 1,257 | 1,183 | 1,201 | -64 | -5.1% | 475,500 |
| 2021/05/11 | 1,245 | 1,297 | 1,202 | 1,265 | +16 | +1.3% | 1,031,500 |
| 2021/05/10 | 1,150 | 1,255 | 1,150 | 1,249 | +90 | +7.8% | 713,800 |
| 2021/05/07 | 1,177 | 1,188 | 1,154 | 1,159 | -3 | -0.3% | 256,200 |
| 2021/05/06 | 1,185 | 1,202 | 1,148 | 1,162 | -28 | -2.4% | 258,900 |
| 2021/04/30 | 1,166 | 1,193 | 1,158 | 1,190 | +37 | +3.2% | 332,700 |
| 2021/04/28 | 1,200 | 1,210 | 1,151 | 1,153 | -70 | -5.7% | 483,400 |
| 2021/04/27 | 1,206 | 1,250 | 1,172 | 1,223 | +18 | +1.5% | 734,000 |
| 2021/04/26 | 1,145 | 1,207 | 1,135 | 1,205 | +71 | +6.3% | 560,700 |
| 2021/04/23 | 1,136 | 1,192 | 1,117 | 1,134 | +8 | +0.7% | 640,900 |
| 2021/04/22 | 1,147 | 1,181 | 1,113 | 1,126 | -74 | -6.2% | 1,685,700 |
| 2021/04/21 | 1,144 | 1,330 | 1,109 | 1,200 | +146 | +13.9% | 7,727,200 |
| 2021/04/20 | 1,050 | 1,072 | 1,043 | 1,054 | -4 | -0.4% | 175,500 |
| 2021/04/19 | 1,049 | 1,064 | 1,027 | 1,058 | +7 | +0.7% | 228,100 |
| 2021/04/16 | 1,070 | 1,070 | 1,040 | 1,051 | -20 | -1.9% | 311,400 |
| 2021/04/15 | 1,023 | 1,080 | 1,022 | 1,071 | -101 | -8.6% | 900,700 |
| 2021/04/14 | 1,180 | 1,191 | 1,161 | 1,172 | +4 | +0.3% | 205,900 |
| 2021/04/13 | 1,156 | 1,181 | 1,151 | 1,168 | +9 | +0.8% | 200,800 |
| 2021/04/12 | 1,200 | 1,208 | 1,153 | 1,159 | -39 | -3.3% | 264,800 |
| 2021/04/09 | 1,175 | 1,208 | 1,171 | 1,198 | +15 | +1.3% | 290,300 |
| 2021/04/08 | 1,158 | 1,184 | 1,142 | 1,183 | +20 | +1.7% | 241,600 |
| 2021/04/07 | 1,180 | 1,188 | 1,161 | 1,163 | -25 | -2.1% | 310,000 |
| 2021/04/06 | 1,203 | 1,209 | 1,171 | 1,188 | -18 | -1.5% | 361,900 |
| 2021/04/05 | 1,245 | 1,250 | 1,203 | 1,206 | -44 | -3.5% | 376,000 |
| 2021/04/02 | 1,203 | 1,250 | 1,203 | 1,250 | +42 | +3.5% | 381,400 |
| 2021/04/01 | 1,193 | 1,218 | 1,167 | 1,208 | +29 | +2.5% | 382,600 |
| 2021/03/31 | 1,150 | 1,201 | 1,135 | 1,179 | +28 | +2.4% | 477,400 |
| 2021/03/30 | 1,141 | 1,180 | 1,132 | 1,151 | -9 | -0.8% | 585,400 |
| 2021/03/29 | 1,233 | 1,238 | 1,153 | 1,160 | -56 | -4.6% | 877,900 |
| 2021/03/26 | 1,235 | 1,248 | 1,201 | 1,216 | +9 | +0.7% | 945,700 |
| 2021/03/25 | 1,350 | 1,365 | 1,192 | 1,207 | -192 | -13.7% | 4,285,300 |
| 2021/03/24 | 1,332 | 1,434 | 1,177 | 1,399 | +265 | +23.4% | 12,313,100 |
1001～
1050
件表示中 / 2829件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| オンコリス | 61,000円 | +3771.0% | - | 0.00% | - | 5.55倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| 扶桑薬 | 208,800円 | +1.6% | -12.7% | 4.31% | 7.75倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 30,200円 | - | - | 0.00% | - | 2.78倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 28,300円 | +0.1% | -70.9% | 0.00% | 47.32倍 | 1.78倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| Ｃｈｏｒｄｉａ | 20,300円 | - | - | 0.00% | - | 4.32倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
